Nanoparticle: An overview of preparation and characterization

Journal of Applied Pharmaceutical Science

Volumn 1, Issue 6, 2011, Pages 228-234

  Pal, Sovan Lal ^a   Jana, Utpal ^a   Manna, P K ^a   Mohanta, G P ^a   Manavalan, R ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Applications; Characterization; Nanoparticles; Preparation

Indexed keywords

EID: 84867831819     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Allemann E., Gurny R., Doekler E. Drug-loaded nanoparticlespreparation methods and drug targeting issues. Eur J Pharm Biopharm. 1993; 39:173-91.
2. Betancor L. and Luckarift HR. 2008 Trends Biotechnol. 26 566 Dunne M, Corrigan
3. Bodmeier R., Chen H. Indomethacin polymeric nanosuspensions prepared by micro- fluidization. J Control Release. 1990; 12:223-33.
4. Catarina PR., Ronald JN., Antonio JR. Nano capsulation 1. Method of preparation of drug - loaded polymeric nanoparticles: Nano technology, Biology and medicine. 2006; 2:8-21.
5. Cheng Y., Wang J., Rao T., He X., Xu T. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. Front Biosci. 2008; 13:1447-71.
6. Chorney M., DAneuberg H., Golomb G. Lipophilic drug loaded nanospheres by nano precipitation: effect of the formulation variables on size, drug recovery and release kinetics. J Control releas.e 2002; 83: 389- 400.
7. Couvreur P., Dubernet C., Puisieux F. Controlled drug delivery with Nano particles:current possibilities and future trends. Eur J Pharm Biopharm. 1995; 41:2-13.
8. DeAssis DN., Mosqueira VC., Vilela JM., Andrade M.S., Cardoso VN. Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99m Technetium - fluconazole nanocapsules. Int J Pharm. 2008; 349: 152 - 160.
9. El-shabouri MH. Positively charged nano particles for improving the oral bioavailability of cyclosporine-A. Int J Pharm. 2002; 249:101-8.
10. Fessi H., Puisieux F., Devissaguet J-P., Ammoury N., Benita S. Nano capsule formation by interfacial deposition following solvent displacement. Int J Pharm. 1989; 55:R1-R4.
11. Fu HL., Cheng SX., Zhang XZ., Zhuo RX. Dendrimers/DNA complexes encapsulated in a water soluble polymer and supported on fast degrading star poly (DL-lactide) for localized gene delivery. J ControlRelease. 2007; 124:181-8.
12. Goldberg M., Langer R., Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym. 2007; 18:241-68.
13. Gurny R., Peppas NA., Harrington DD., Banker GS. Development of biodegradable and injectable lattice for control release of potent drugs. Drug Dev Ind Pharm. 1981; 7:1-25.
14. Hahens WI., Oomen AG., deJong WH., Cassee FR. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regulatory Toxicology and Pharmacology. 2007; 49:217-229.
15. Hett A. Nanotechnology: small matters, many unknown. 2004. Hoet PMH., Brnske HI., Salata OR. Nano particles known and unknown health risk. J nanobiotecnol. 2004; 2:12.
16. Jaiswal J., Gupta SK., Kreuter J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification solvent evaporation process. J Control Release. 2004; 96:1692-178.
17. Jani P., Halbert GW., Langridge J., Florence AT. Nanoparticles uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol.1990;42(12) :812-826.
18. Jani P., Halbert GW., Langridge J., Florence AT. The uptake and translocation of latex nanosphere and microsphere after oral administration to rats. J Pharm Pharmacol. 1989; 41(12) 809-812.
19. Jores K., Mehnert W., Drecusler M., Bunyes H., Johan C., MAder K. Investigation on the stricter of solid lipid nanopartuicles and oil-loaded solid nanoparticles by photon correlation spectroscopy, fieldflow fractionasition and transmission electron microscopy. J Control Release. 2004; 17: 217- 227.
20. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao JK., Kissel T. Biodegradable nano particles for oral delivery of peptides: is there a role for polymer to affect mucosal uptake? Eur J Pharm Biopharm. 2000; 50:147-60.
21. Kohler M., Fritzsche W. Nanotechnology, an introduction to nanostructuring
22. Koosha F., Muller RH., Davis SS., Davies MC. The surface chemical structure of poly ( -hydroxybutyrate) microparticles produced by solvent evaporation process. J Control Release. 1989; 9:149-57.
23. Kreuter J. Physicochemical characterization of polyacrylic nanoparticles. Int. J. Pharm. 1983; 14: 43 -58.
24. Lademann J., Weigmann H., Rickmeyer C., Barthelmes H., Schaelmes H., Mueller G., Sterry W. Penetration of Titanium Dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacology and Applied Skin Physiology. 1999; 12: 247- 256.
25. Lambert G., Fattal E., Couvreur P. Nanoparticulate system for the delivery of antisense oligonucleotides. Adv Drug Deliv Rev. 2001; 47:99-112.
26. Larson DR., Zipfel WR., Williams RM., Clark SW., Bruchez MP., Wise FW. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science. 2003; 300:1434-6.
27. Lee KP., Kelly DP., Oneal FO., Kennedy GL. Lung response to ultrafine kertar aramid synthetic fibrils following 2-year inhalation exposure in rats. Findam Appl Toxicol. 1998;11:1-20.
28. Lemarchand C., Gref R., Passirani C., Garcion E., Petri B., Muller R. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials. 2006; 27:108-18.
29. Li Y., Cheng Y., Xu T. Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review. Curr Drug Discov Technol. 2007; 4:246-54.
30. Magenhein B., Levy MY., Benita S. A new in vitro technique for the evaluation of drug release profile from colloidal carriersultrafiltration technique at low pressure. Int. J. Pharm. 1993; 94: 115-123.
31. Mecke A., Uppuluri S., Sassanella TM., Lee DK., Ramamoorthy A., Baker Jr JR. Direct observation of lipid bilayer disruption by poly (amidoamine) dendrimers. Chem Phys Lipids. 2004; 132:3-14.
32. Molpeceres J., Aberturas MR., Guzman M. Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization. J Microencapsul. 2000; 17: 599-614.
33. Muhlen AZ., Muhlen EZ., Niehus H., Mehnert W. Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res. 13:1411- 1416(1996).
34. Pangi Z., Beletsi A., Evangelatos K. PEG-ylated nanoparticles for biological and pharmaceutical application. Adv Drug Del Rev. 2003; 24: 403- 419.
35. Polakovic M., Gorner T., Gref R., Dellacherie E. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release. 1999; 60: 169 -177.
36. Quintanar-Guerrero D., Allemann E., Fessi H., Doelker E. Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998; 24:1113-28.
37. Redhead H M., Davis SS. and Illum L. J. Control. Release. 2001; 70: 353.
38. Scholes PD., Coombes AG., Illum L., Davis SS., Wats JF., Ustariz C., Vert M., Davies MC. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J control Release. 1999; 59: 261 - 278.
39. Shi HG., Farber L., Michaels JN., Dickey A., Thompson KC., Shelukar SD., Hurter PN., Reynolds SD., Kaufman MJ. Characterization of crystalline drug nanoparticles using atomic force microscopy and complementary techniques. Pharm Res. 20: 479 - 484 (2003).
40. Song CX., Labhasetwar V., Murphy H., Qu X., Humphrey WR.. Shebuski RJ., Levy RJ. Formulation and characterization of biodegradables nanoparticles for intravascular local drug delivery. J Control Release. 1997; 43:197- 212.
41. Soppinath KS., Aminabhavi TM., Kulkurni AR., Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001; 70:1-20.
42. Tabata J., Ikada Y. Protein pre-coating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. Pharm Res. 1989; 6:296-301.
43. Takeuchi H., Yamamoto Y. Mucoadhesive nanoparticulate system for peptide drug delivery. Adv Drug Del Rev. 2001; 47: 39-54.
44. Tice TR., Gilley RM. Preparation of injectable controlledrelease microcapsules by solvent- evaporation process. J Control Release. 1985; 2:343-352.
45. Tomalia DA. Birth of a new macromolecular architecture: Dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichimica Acta. 2004;37(2):39-57
46. Tomalia DA. Dendrimer as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichmica Acta. 2004; 37(2):39-57.
47. Ubrich N., Bouillot P., Pellerin C., Hoffman M., Maincent P. Preparation and characterization of propanolol hydrochloride nano particles : A comparative study. J Control release. 2004:291-300.
48. Ueda H., Kreuter J. Optimization of the preparation of loperamide- loaded poly (l-lactide) nanoparticles by high pressure emulsification solvent evaporation. J Microencapsul. 1997; 14:593-605.
49. Vandervoort J., Ludwig A. Biodegradable stabilizers in the preparation of PLGA nano particles: a factorial design study. Int J Pharm. 2002; 238:77-92.
50. Vargas A., Pegaz B., Devefve E., Konan- Kouakou Y., Lange N., Ballini JP. Improved photodynamic activity of porphyrin loaded into nano particles: an in vivo evaluation using chick embryos. Int J Pharm. 2004; 286: 131- 45.
51. Wiener EC., Brechbiel MW., Brothers H., Magin RL., Gansow OA.,Tomalia DA. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med. 1994; 31:1-8.
52. Yoo HS., Oh JE., Lee KH., Park TG. Biodegradable nano particles containing PLGA conjugates for sustained release. Pharm Res. 1999: 16: 1114-8.